445 related articles for article (PubMed ID: 23122037)
1. Imaging prostate cancer.
Jung AJ; Westphalen AC
Radiol Clin North Am; 2012 Nov; 50(6):1043-59. PubMed ID: 23122037
[TBL] [Abstract][Full Text] [Related]
2. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
[TBL] [Abstract][Full Text] [Related]
3. Inter-reader agreement of multi-parametric MR imaging for the detection of prostate cancer: evaluation of a scoring system.
Quentin M; Arsov C; Röhlen S; Klasen J; Antoch G; Albers P; Blondin D
Rofo; 2012 Oct; 184(10):925-9. PubMed ID: 22744328
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ
Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
[TBL] [Abstract][Full Text] [Related]
5. MR-perfusion (MRP) and diffusion-weighted imaging (DWI) in prostate cancer: quantitative and model-based gadobenate dimeglumine MRP parameters in detection of prostate cancer.
Scherr MK; Seitz M; Müller-Lisse UG; Ingrisch M; Reiser MF; Müller-Lisse UL
Eur J Radiol; 2010 Dec; 76(3):359-66. PubMed ID: 20471189
[TBL] [Abstract][Full Text] [Related]
6. [Multiparametric magnetic resonance imaging of the prostate - technique and clinical applications].
Franiel T
Rofo; 2011 Jul; 183(7):607-17. PubMed ID: 21487980
[TBL] [Abstract][Full Text] [Related]
7. Update of prostate magnetic resonance imaging at 3 T.
Kim CK; Park BK
J Comput Assist Tomogr; 2008; 32(2):163-72. PubMed ID: 18379296
[TBL] [Abstract][Full Text] [Related]
8. MR imaging and MR spectroscopy in prostate cancer management.
Katz S; Rosen M
Radiol Clin North Am; 2006 Sep; 44(5):723-34, viii. PubMed ID: 17030223
[TBL] [Abstract][Full Text] [Related]
9. Role of high-field MR in studies of localized prostate cancer.
Lagemaat MW; Scheenen TW
NMR Biomed; 2014 Jan; 27(1):67-79. PubMed ID: 23703839
[TBL] [Abstract][Full Text] [Related]
10. MR imaging and MR spectroscopic imaging of prostate cancer.
Rajesh A; Coakley FV
Magn Reson Imaging Clin N Am; 2004 Aug; 12(3):557-79, vii. PubMed ID: 15271371
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer imaging.
Fuchsjäger M; Shukla-Dave A; Akin O; Barentsz J; Hricak H
Acta Radiol; 2008 Feb; 49(1):107-20. PubMed ID: 18210320
[TBL] [Abstract][Full Text] [Related]
12. Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy.
Goris Gbenou MC; Peltier A; Addla SK; Lemort M; Bollens R; Larsimont D; Roumeguère T; Schulman CC; van Velthoven R
Urol Int; 2012; 88(1):12-7. PubMed ID: 22004874
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer imaging: what the urologist wants to know.
Talab SS; Preston MA; Elmi A; Tabatabaei S
Radiol Clin North Am; 2012 Nov; 50(6):1015-41. PubMed ID: 23122036
[TBL] [Abstract][Full Text] [Related]
14. Multiparametric magnetic resonance imaging in the detection of prostate cancer.
Durmus T; Baur A; Hamm B
Aktuelle Urol; 2014 Mar; 45(2):119-26. PubMed ID: 24700068
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
16. [Magnetic resonance imaging in the diagnosis of prostate cancer: problems and capabilities].
Revizonskaia AV; Ridén TV
Vestn Rentgenol Radiol; 2013; (5):50-6. PubMed ID: 25672154
[TBL] [Abstract][Full Text] [Related]
17. Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility.
Hambrock T; Fütterer JJ; Huisman HJ; Hulsbergen-vandeKaa C; van Basten JP; van Oort I; Witjes JA; Barentsz JO
Invest Radiol; 2008 Oct; 43(10):686-94. PubMed ID: 18791410
[TBL] [Abstract][Full Text] [Related]
18. Imaging of recurrent prostate cancer.
Fütterer JJ
Radiol Clin North Am; 2012 Nov; 50(6):1075-83. PubMed ID: 23122039
[TBL] [Abstract][Full Text] [Related]
19. Local staging of prostate cancer with MRI.
Soylu FN; Eggener S; Oto A
Diagn Interv Radiol; 2012; 18(4):365-73. PubMed ID: 22399364
[TBL] [Abstract][Full Text] [Related]
20. Prostate MR imaging at 3T using a phased-arrayed coil in predicting locally recurrent prostate cancer after radiation therapy: preliminary experience.
Kim CK; Park BK; Park W; Kim SS
Abdom Imaging; 2010 Apr; 35(2):246-52. PubMed ID: 19130116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
